Pulse Explore Journal Club Debates Trending Researchers Journals

Home Explore Journal Club Trending

⌘+K

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy | Synapse

July 25, 2014Frontiers in Immunology74 citationsOpen Access

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy

SAShanjana Awasthi

Key Points

Key points are not available for this paper at this time.

Abstract

OPINION article Front. Immunol., 25 July 2014Sec. Cancer Immunity and Immunotherapy Volume 5 - 2014 | https://doi.org/10.3389/fimmu.2014.00328

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Shanjana Awasthi (2014) studied this question.

synapsesocial.com/papers/6a7107a08031ec7bb1dcb9ac https://doi.org/https://doi.org/10.3389/fimmu.2014.00328

Ask AI

Helpful

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene1998 · 7,641 citations
2The Protective Role of Host Toll-Like Receptor-4 in Acute Graft-Versus-Host Disease2010 · 38 citations
3TLR4 Signaling Promotes Immune Escape of Human Colon Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance2012 · 50 citations
4TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis : Role of IL-17-Producing T Cells2006 · 353 citations
5Glycolipids and Benzylammonium Lipids as Novel Antisepsis Agents: Synthesis and Biological Characterization2009 · 66 citations